- In June 2024, HonorHealth Research Institute became the first in the Southwest to implant a new stroke prevention stent. The patient underwent a non-surgical, catheter-based procedure involving this innovative stent, which works to remove blockages in neck arteries that could lead to a life-threatening stroke by depriving the brain of oxygen
- In March 2024, SafeGuard Surgical announced that its LeakGuard biodegradable stent received breakthrough device designation from the FDA. Along with this regulatory achievement, the company revealed the successful completion of its Series A funding round, with Tom Pepin, principal at Tapper Ventures, leading the investment. NFL quarterback Jameis Winston was also among the early investors in the company
